Posted by: Audrey Erbes | October 31, 2016

Drug Industry Will Come Under Severe Pricing Scrutiny under Clinton Presidency

Drug Industry Will Come Under Severe Pricing Scrutiny under Clinton Presidency

Under a Clinton presidency, a reduction in pharmaceutical pricing will be a priority. Clinton has had a person working on this back as far as her 2008 presidential run. Neera Tanden, president and CEO of progressive think tank the Center for American Progress (CAP) and Ezekiel Emanuel Chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania. recently argued against PhRMA’s Lori Reilly and the Manhattan Institute for Policy Research’s Paul Howard the motion that drug prices are fueling runaway. Health care costs.

(Debating Drug Prices, By Steve Usdin, Washington Editor, BioCentury, week of Oct. 31, 2016, pp. 14-15}.

 Highlights for Bay Area Bioscience Meetings Week of Oct. 30, 2016

  • Bio2Device Group, Tuesday Morning, Nov. 1, 2016, Topic: “Artificial Intelligence and Robotics for Chronic Disease Management,” Speaker: Cory Kidd, Founder and CEO, Catalia Health
  • JLABS, Tuesday, Nov. 1, 2016, Topic: “Why Ya Buggin’ Out? Regulatory Hurdles and Other Obstacles on the Path to Microbiome Market?” Speakers:
    Vern Norviel | Partner, Wilson Sonsini Goodrich & Rosati;  KT Moortgat |CEO, Osel,  Emma Taylor | Co-Founder & CEO, Naked Biome,
    [Moderator] Stephanie Robertson, | New Ventures, Johnson & Johnson (J&J) Innovation, California
  • ACRP, Tuesday MidDay, Nov. 1, 2016, Topic: “Webinar: Diverse Women in Clinical Trials Webinar Series – Part I: Planning for Diversity”
  • ASQ Course, Friday Morning, Nov. 4, 2016, Event: “B113 – Preparing & Submitting 510K’s & PMA’s”

You can download details for the above events in a complete PDF list of upcoming events through Dec.  2016 by right clicking on audreys-picks-oct-30-2016.  A new list of jobsthatcrossedmydeskthrough-oct-30-2016 can also be downloaded.




  1. Interesting to see the detail on this, specifically the named advisors. Thank you.

    If you have it at your fingertips, I’m curious to know the proportion of healthcare cost increases from drug cost increases.

    As I understood it, healthcare industry, & specifically insurers, were the largest contributors to Obama’s campaigns. Are they also significant contributors to HRC’s?

    Hope you are doing well. I’m again on the East Coast, the good news is that my mother us doing much better.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: